NeurAxis (NRXS) Stock Price, News & Analysis

Company Overview

NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome. The company sells its products to healthcare companies, including hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.

Key Stats

• Today's Range: $2.28 to $2.32
• 50-Day Range: $2.31 to $3.14
• 52-Week Range: $2.05 to $3.78
• Volume: 12,202 shs
• Average Volume: 21,764 shs
• Market Capitalization: $16.59 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

NRXS Stock Analysis - Frequently Asked Questions

How have NRXS shares performed this year?

NeurAxis' stock was trading at $2.35 at the beginning of 2025. Since then, NRXS stock has decreased by 1.7% and is now trading at $2.31.
View the best growth stocks for 2025 here.

How were NeurAxis' earnings last quarter?

NeurAxis, Inc. (NASDAQ:NRXS) posted its quarterly earnings data on Tuesday, November, 12th. The company reported ($0.25) earnings per share for the quarter. The business earned $0.67 million during the quarter.

When did NeurAxis IPO?

NeurAxis (NRXS) raised $7 million in an initial public offering (IPO) on Wednesday, August 9th 2023. The company issued 1,098,667 shares at $6.00 per share.

Who are NeurAxis' major shareholders?

Top institutional investors of NeurAxis include Bank of Montreal Can (1.94%), Parsons Capital Management Inc. RI (1.67%) and Citadel Advisors LLC (0.66%).

How do I buy shares of NeurAxis?

Shares of NRXS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of NeurAxis own?

Based on aggregate information from My MarketBeat watchlists, some other companies that NeurAxis investors own include AutoZone (AZO), Intel (INTC), Meta Platforms (META), AMMO (POWW), SPDR S&P 500 ETF Trust (SPY), TJX Companies (TJX) and ETRACS Crude Oil Shares Covered Call ETN (USOI).

Company Calendar

• Last Earnings: 11/12/2024
• Today: 2/22/2025
• Next Earnings (Estimated): 4/15/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Electromedical equipment
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:NRXS
• CUSIP: N/A
• CIK: 1933567
• Web: neuraxis.com
• Phone: (812) 689-0791
• Fax: N/A
• Employees: 19
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($1.84)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-14,630,000.00
• Net Margins: -492.76%
• Pretax Margin: -341.35%
• Return on Equity: N/A
• Return on Assets: -641.25%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.24
• Quick Ratio: 0.23

Sales & Book Value

• Annual Sales: $2.46 million
• Price / Sales: 6.74
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.27) per share
• Price / Book: -8.56

Miscellaneous

• Outstanding Shares: 7,180,000
• Free Float: 6,085,000
• Market Cap: $16.59 million
• Optionable: Not Optionable
• Beta: 4.22